Dziva Francis, Vlisidou Isabella, Crepin Valérie F, Wallis Timothy S, Frankel Gad, Stevens Mark P
Division of Microbiology, Institute for Animal Health, Compton, Berkshire, RG20 7NN, United Kingdom.
Vet Microbiol. 2007 Jul 20;123(1-3):254-61. doi: 10.1016/j.vetmic.2007.02.016. Epub 2007 Feb 23.
Enterohaemorrhagic Escherichia coli (EHEC) infections in humans are frequently associated with direct or indirect contact with ruminant faeces and may result in haemorrhagic colitis and severe renal and neurological sequelae. Broadly cross-protective vaccines for control of EHEC do not yet exist and the molecular mechanisms that influence bacterial persistence in the intestines of ruminants are incompletely understood. We sought to determine the role in colonisation and protective efficacy of EspA, which forms a filamentous extension of the locus of enterocyte effacement-encoded type III secretion system that injects EHEC proteins into enterocytes. A non-polar deletion of espA severely impaired the ability of E. coli O157:H7 to colonise the intestines of calves. Vaccination of calves with highly purified recombinant EspA induced high-titre antigen-specific IgG1 (also reactive to native EspA) and salivary IgA responses, however these responses did not protect calves against intestinal colonisation by E. coli O157:H7 upon experimental infection.
人类感染肠出血性大肠杆菌(EHEC)通常与直接或间接接触反刍动物粪便有关,可能导致出血性结肠炎以及严重的肾脏和神经后遗症。目前尚无用于控制EHEC的广泛交叉保护疫苗,且影响细菌在反刍动物肠道中持续存在的分子机制尚未完全明确。我们试图确定EspA在定殖和保护效力方面的作用,EspA形成肠细胞损伤位点编码的III型分泌系统的丝状延伸,该系统将EHEC蛋白注入肠细胞。espA的非极性缺失严重损害了大肠杆菌O157:H7定殖于小牛肠道的能力。用高度纯化的重组EspA对小牛进行疫苗接种可诱导产生高滴度的抗原特异性IgG1(也对天然EspA有反应)和唾液IgA反应,然而,这些反应并不能保护小牛在实验性感染时免受大肠杆菌O157:H7的肠道定殖。